My Cart
In stock

Lavistina 8 Mg 100 Tablet

Cardiovascular

In stock

SKU: 10331019313

Lavistina 8 mg tablets are a prescription medication containing Betahistine, specifically formulated to alleviate symptoms associated with Meniere's disease, such as vertigo, tinnitus, and hearing loss. It works by enhancing blood flow in the inner ear, helping to reduce fluid pressure. This medication helps manage attacks of vertigo and improve overall inner ear function.

Lavistina 8 mg 100 Tablets: Effective Relief for Meniere's Disease


Lavistina 8 mg tablets are a prescription medication formulated with Betahistine, specifically designed to offer comprehensive relief from the distressing symptoms associated with Meniere's disease.
It works by enhancing blood flow in the inner ear, helping to reduce fluid pressure and manage attacks of vertigo, tinnitus, and hearing loss.

Benefits of Using Lavistina 8 mg Tablets


Alleviates debilitating vertigo attacks, providing stability and reducing dizziness.
Reduces the intensity and frequency of tinnitus (ringing in the ears).
Helps to improve or stabilize hearing loss, a common symptom of Meniere's disease.
Enhances blood circulation within the inner ear, crucial for maintaining inner ear fluid balance.
Contributes to reducing endolymphatic pressure, addressing a primary cause of Meniere's symptoms.
Improves overall inner ear function, leading to a better quality of life for affected individuals.

How to Use Lavistina 8 mg Tablets


It is crucial to follow your doctor's instructions precisely regarding dosage and duration of treatment.
1. The typical dosage for adults is one 8 mg tablet taken three times daily.
2. Take the tablets preferably with meals to minimize gastrointestinal discomfort.
3. Swallow the tablet whole with a glass of water; do not crush, chew, or break it.
4. Continue treatment as prescribed by your healthcare professional, even if symptoms improve.
5. Do not exceed the recommended dose.

Caution & Warnings


  • Always consult your physician before starting or discontinuing any medication.
  • Do not use Lavistina if you are allergic to Betahistine or any other ingredients in the tablet.
  • Patients with pheochromocytoma (a rare tumor of the adrenal gland) should not use this medication.
  • Use with caution in patients with peptic ulcers or a history of peptic ulcers.
  • Individuals with bronchial asthma should be monitored closely during treatment.
  • Not recommended for use during pregnancy or breastfeeding unless strictly necessary and advised by a doctor.
  • May cause mild gastrointestinal disturbances such as nausea, indigestion, or headache in some individuals.
  • If you experience severe side effects or an allergic reaction, seek immediate medical attention.
  • Keep out of reach of children.
  • Do not drive or operate machinery if you experience dizziness or drowsiness.

Ingredients


Each Lavistina 8 mg tablet contains:
  • Active Ingredient: Betahistine Dihydrochloride 8 mg
  • Excipients: Microcrystalline Cellulose, Mannitol, Talc, Magnesium Stearate, Colloidal Anhydrous Silica.

Product Details


  • **Drug Type:** Prescription Medication
  • **Form:** Tablets
  • **Strength:** 8 mg Betahistine Dihydrochloride
  • **Package Size:** 100 Tablets
  • **Administration Route:** Oral
  • **Manufacturer:** Hikma Pharmaceuticals
  • **Brand:** Lavistina
More Information
Brand Lavistina
Is Wasfaty Product No
Gtin 0628514700188000
Recommended Sale Price 50.4
Principle Betahistine Dihydrochloride
Ingredient Name BETAHISTINE DIHYDROCHLORIDE
SFDA Reg. No 2510211229
IBC 0628514700188000
Drug Type Prescription
Scientific Name Betahistine dihydrochloride
Strength 8
Strength Unit mg
Form Tablet
Admin Route Oral
Size 100
Size Unit Tablets
Package Types Blister pack, Carton
Package Size 100 tablets per pack
Storage conditions Store below 30°C, away from moisture and direct sunlight.
Refrigerator Storage No
Distribute area Saudi Arabia, Egypt